Fractyl Health, Inc. Revenue from Contract with Customer, Including Assessed Tax
Fractyl Health, Inc. (GUTS) reported Revenue from Contract with Customer, Including Assessed Tax of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-03-24
- Fractyl Health, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2024-12-31 was $3.00K, a 57.14% decline year-over-year.
- Fractyl Health, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2024-09-30 was $14.00K, a 61.11% decline year-over-year.
- Fractyl Health, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2024-06-30 was $43.00K, a 40.28% decline year-over-year.
- Fractyl Health, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2024-03-31 was $33.00K, a 560.00% increase year-over-year.
- Fractyl Health, Inc. revenue from contract with customer, including assessed tax for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Fractyl Health, Inc. revenue from contract with customer, including assessed tax for fiscal 2024 was $93.00K, a 22.50% decline from fiscal 2023.
- Fractyl Health, Inc. revenue from contract with customer, including assessed tax for fiscal 2023 was $120.00K.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-24 | |||
| 2024-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $17.00K derived: sum of 2 quarters · filed 2026-03-24 | $60.00K derived: sum of 3 quarters · filed 2026-03-24 | $93.00K 10-K · filed 2026-03-24 |
| 2024-09-30 | $14.00K 10-Q · filed 2025-11-12 | $57.00K derived: sum of 2 quarters · filed 2025-11-12 | $90.00K 10-Q · filed 2025-11-12 | $97.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $43.00K 10-Q · filed 2025-08-12 | $76.00K 10-Q · filed 2025-08-12 | $83.00K derived: sum of 3 quarters · filed 2025-08-12 | $119.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $33.00K 10-Q · filed 2025-05-13 | $40.00K derived: sum of 2 quarters · filed 2025-05-13 | $76.00K derived: sum of 3 quarters · filed 2025-05-13 | $148.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $43.00K derived: sum of 2 quarters · filed 2025-03-03 | $115.00K derived: sum of 3 quarters · filed 2025-03-03 | $120.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $36.00K 10-Q · filed 2024-11-12 | $108.00K derived: sum of 2 quarters · filed 2024-11-12 | $113.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $72.00K 10-Q · filed 2024-08-14 | $77.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $5.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |